Ethical and Administrative Implications of Nanoscale Technology for Efficient and Safe Delivery of Drugs :Analytical and Regulatory Aspects
By: Tiwari, Gaurav
.
Contributor(s): Tiwari, Ruchi.
Publisher: Bengaluru Indian journal of pharmaceutical education and research 2019Edition: Vol.53(20, Apr-Jun.Description: 192-201p.Subject(s): PHARMACEUTICSOnline resources: Click here
In:
Indian journal of pharmaceutical education and researchSummary: Background: Cutting-edge issues for nanomedicine involve knowledge of the problems associated with toxicity and environmental effect of nanoscale substances (substances whose structure is on the dimensions of nanometers, i.e. billionths of a meter). Nanoparticles are able to reach inner biomolecules, which is not possible for larger debris. Materials and Methods: The nanosuspension turned into analytically characterized and subjected to regulatory aspects. Scientific facts used to make regulatory decisions about merchandise starting from cosmetics to chemotherapy agents to food packaging, FDA has lengthy encountered the combination of promise, threat and uncertainty that accompanies emerging technologies. Nanotechnology is not specific on this regard. Present article covered about regulatory aspects of Abbreviated New Drug Application (ANDA) and Registration, Evaluation, Authorisation and Restriction of Chemicals(REACH).Conclusion: The objective of this review is to know about the FDA regulations towards nanotechnology and various techniques used to analyze this tiny technology for drug delivery.
| Item type | Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|
Articles Abstract Database
|
School of Pharmacy Archieval Section | Not for loan | 2019972 |
Background: Cutting-edge issues for nanomedicine involve knowledge of the problems associated with toxicity and environmental effect of nanoscale substances (substances whose structure is on the dimensions of nanometers, i.e. billionths of a meter). Nanoparticles are able to reach inner biomolecules, which is not possible for larger debris. Materials and Methods: The nanosuspension turned into analytically characterized and subjected to regulatory aspects. Scientific facts used to make regulatory decisions about merchandise starting from cosmetics to chemotherapy agents to food packaging, FDA has lengthy encountered the combination of promise, threat and uncertainty that accompanies emerging technologies. Nanotechnology is not specific on this regard. Present article covered about regulatory aspects of Abbreviated New Drug Application (ANDA) and Registration, Evaluation, Authorisation and Restriction of Chemicals(REACH).Conclusion: The objective of this review is to know about the FDA regulations towards nanotechnology and various techniques used to analyze this tiny technology for drug delivery.
Click on an image to view it in the image viewer
There are no comments for this item.